null - FindTrial

NA - IFM2016-03

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2017-001446-10-FR

Enrollment

Registered

2017-10-20

Start date

2018-09-27

Completion date

Unknown

Last updated

2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NA MedDRA version: 20.0 Level: LLT Classification code 10028566 Term: Myeloma System Organ Class: 100000004864

Interventions

Trade Name: Empliciti Product Name: Empliciti Pharmaceutical Form: Powder for solution for infusion CAS Number: 915296-00-3 Concentratio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: NA Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 35

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Secondary Objective: NA;Main Objective: NA;Primary end point(s): NA;Timepoint(s) of evaluation of this end point: NA	—

Secondary

Measure	Time frame
Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: NA	—

Countries

France

Contacts

Public ContactDRCI Hôpital St Louis

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

maud.jacubert@aphp.fr

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026